Overview
Employees
1,142 employees
Revenue
$100 to $500 million (USD) per year
Competitors
American Diabetes Association, March of Dimes, American Heart Association
Headquarters
New York, New York
Category
Charitable Organizations & s
JDRF is the only global organization with a strategic research plan to end type 1 diabetes (T1D). Our plan ensures that there will be an ongoing stream of life-changing therapies moving from development through to commercialization that lessen the impact of T1D. We want to keep people with T1D healthy and safe today until we reach our ultimate goal of a cure and universal prevention of T1D. JDRF collaborates with a wide spectrum of partners at every stage of the drug delivery pipeline and is the only organization with the scientific resources, regulatory influence, and a strategic plan to deliver a world without T1D. JDRF’s influence and leadership extends beyond funding research. We strategically partner with industry, governments, foundations, academia and clinicians, because curing T1D is a global, coordinated effort with JDRF at the center. For more information, please visit www.jdrf.org. JDRF T1D Fund LLC operates as a non profit organization. The Organization focuses on early-stage investments to accelerate the delivery of treatments, preventions, and cures to patients fighting against type 1 diabetes. JDRF T1D Fund serves patients in the State of New York. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.As the largest charitable supporter of T1D research, JDRF is currently sponsoring $568 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research.
